Abstracts tagged "polymyalgia rheumatica and rheumatoid arthritis (RA)"

Abstract Number: 2282 • 2013 ACR/ARHP Annual Meeting
Performance Of The 2010 ACR/EULAR Classification Criteria For Rheumatoid Arthritis In a Group Of Elderly Onset Patients
Pierluigi Macchioni¹, Giovanni Barausse², Luigi Boiardi¹, Giulia Pazzola¹, Roberto Bortolotti², Giovanna Restuccia¹, Maria Grazia Catanoso¹, Giuseppe Paolazzi³ and Carlo Salvarani⁴, ¹Rheumatology Service, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, ²Rheumatology, Ospedale di Trento, Trento, Italy, ³Rheumatology, Ospedale Santa Chiara, Trento, Italy, ⁴Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy
Background/Purpose: To evaluate the diagnostic ability of the 2010 ACR/EULAR classification criteria for Rheumatoid arthritis (RA) in a consecutive series of elderly onset (> 50y)…
Abstract Number: 2025 • 2013 ACR/ARHP Annual Meeting
Distinctive Expression Profiles Of Long Intergenic Non-Coding RNA Between Polymyalgia Rheumatica and Rheumatoid Arthritis Might Contains Helpful Suggestions For Understanding and Discriminating These Diseases
Yoshinobu Koyama¹, Motohiko Tanino², Hirokazu Shiraishi³, Shuji Nagano⁴, Toshiyuki Ota⁴ and Toshie Higuchi⁵, ¹Division of Rheumatology, Okayama Red Cross General Hospital, Okayama, Japan, ²DNA Chip Research Inc., Yokohama, Japan, ³Orthopedics, Iizuka Hospital, Iizuka, Japan, ⁴Center for Rheumatic Diseases, Iizuka Hospital, Iizuka, Japan, ⁵Center for Autoimmune Diseases, Division of Rheumatology, Japan Red Cross Okayama Hospital, Okayama, Japan
Background/Purpose: There are many clinical similarities between polymyalgia rheumatica (PMR) and rheumatoid arthritis (RA). It has been reported that the specificity for discriminating PMR from…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].